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Abstract
Background: Maternal allergic disease history and impaired regulatory T-cells (Tregs) are critical risk factors for
allergy development in children. However, the mechanisms that underlie these risk factors remain poorly defined.
Therefore, the aim of this study was to assess whether maternal allergies affect the Tregs of offspring and lead to
allergy development in childhood.
Methods: A total of 332 mothers of healthy newborns (234 from no allergic mothers, 98 from allergic mothers)
were recruited to this study. Detailed questionnaires were administered yearly to determine the allergy status of the
mothers and the newborns from birth to 3 years of age. Cord blood samples obtained at the time of birth were
analysed for Treg counts, as well Treg activity, based on their response to Toll-like receptor (TLR) stimuli such as
lipid A (LPA) and peptidoglycans (PPG). Surface markers, associated genes, suppressive capacity, and cytokine levels
of Tregs were also measured. Possible correlations between Treg activity and maternal or neonate allergies were
assessed. In addition, environmental microbial content and other known risk factors for allergies were measured.
Results: Cord blood mononuclear cells (CBMCs) from offspring with allergic mothers showed fewer CD4+CD25+FOXP3+ T
cells, lower expression levels of associated genes, and reduced cytokine production of interleukin (IL)-10 and
interferon-γ (P < 0.05), especially via the PPG-TLR2 pathway. Suppression of effector T cells by Tregs from children of
mothers with allergies was impaired, especially IL-13 production by Type 2 T helper (Th2) cells (P = 0.026). Children
who developed allergies in the first 3 years of life had lower numbers of CD4+CD25+FOXP3+ T cells and reduced FOXP3
expression and IL-10 production as newborns (P < 0.05). Maternal allergic background was identified as a risk factor for
allergy development in the children (Odds ratio (OR) = 2.46, 95 % CI = 1.05–5.79); while declining Treg numbers, IL-10
production, and FOXP3 expression in neonates (PPG and LPA stimulated) were identified as independent risk factors
for allergic diseases in offspring at 3 years of age after adjusting for maternal allergic history and environmental
factors (P < 0.05).
Conclusion: Maternal allergy correlated with impaired Tregs in neonates, and this could enhance the susceptibility of
offspring to allergic diseases in early childhood due to an imbalance of Th1 and Th2 cells.
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Background
The incidence of childhood allergic diseases has exhibited a
marked increase in recent years, with the incidence in
China being greater than 3.3 % [1]. A family history of aller-
gic diseases, especially maternal allergies, is associated with
a high likelihood of childhood allergy development [2, 3].
Some prospective cohort studies of Western countries have
shown that susceptibility to allergic diseases in children may
occur early in life [4–6], and during this time period regula-
tory T-cells (Tregs) could be involved. However, analogous
follow-up studies in China have not been performed.
Because Tregs influence the early steps of allergy initi-
ation [7], it is important to measure Treg cell abundance.
New research has found that CD4+CD25+ FOXP3+ T cells
were found to be excellent markers for Tregs [8]. Stable
expression of FOXP3 has been observed in mature Tregs,
and this expression profile was found to be highly specific
for Tregs [9]. Other Treg specific genes include
glucocorticoid-induced TNFR-related protein (GITR) and
lymphocyte activation gene 3 (LAG-3) [10, 11]. Further-
more, interleukin (IL)-10 is a relatively specific cytokine of
Tregs, and secretion of this cytokine may act as an add-
itional marker for Tregs [12]. The suppressive capacity of
Tregs is required to maintain the balance of T helper (Th)
cells, including Th1, Th2, and Th17 cells. Unchecked
proliferation of these Th cell populations has been shown
to play a key role in the pathogenesis of allergic diseases.
Toll-like-receptor (TLR)-induced innate immune re-
sponses affect the early differentiation of T cells. In particu-
lar, TLR2 and TLR4 are induced by peptidoglycans (PPG)
and lipid A (LPA), respectively, and have been shown to be
important mediators of T cell differentiation. Immune sys-
tem stimulation may be critical to early immune modula-
tion, and several studies have reported that young children
growing up in environments rich in microbial stimuli have
a lower risk of allergy [13, 14]. At the molecular level, acti-
vation of the TLR2/4 pathways has been shown to upregu-
late Tregs and induce cytokine secretion in both children
and animal models with allergy development [13–15].
We hypothesize that the extent of the T cell response to
TLR2/4 stimulation may be influenced by a maternal back-
ground of atopy. Therefore, the aim of the present study
was to examine whether TLR2/4 stimulation influences im-
munity in addition to the activity of T cell subsets such as
Tregs. Secretion of cytokines IFN-γ (Th1 cells), IL-13 (Th2
cells), and IL-17 (Th17 cells) were also examined. Further-
more, follow-up studies were conducted to assess whether
maternal allergic status affected the susceptibility of devel-
oping allergic diseases in the first three years of childhood.
Methods
Study populations
A total of 332 mothers of healthy newborns in the city of
Changchun, China were recruited to this study. Of these
mothers, 234 had no allergies, while 98 had been diagnosed
with allergies. We defined maternal allergy history as a
diagnosis of asthma [16], allergic rhinitis [17], and/or aller-
gic eczema [18] with at least one positive specific IgE (sIgE).
Enrollment occurred from January 2012 through December
2012 with the approval of the ethics committee of the
Second Hospital of Jilin University (2012–003). Pregnant
mothers were approached at least one month before deliv-
ery for consent and they completed a detailed questionnaire
that assessed maternal and infant data. In addition, cord
blood was collected from each neonate (n = 332). The study
inclusion criteria consisted of healthy neonates and
mothers with uncomplicated pregnancies. Exclusion criteria
were preterm deliveries, parents with autoimmune diseases,
perinatal infections, maternal antibiotic or systemic gluco-
corticoid use in the last trimester, rural newborns, un-
healthy newborns, or paternal allergic diseases.
Follow-up studies were conducted from 2012 to 2015
by questionnaire when the children were 12, 24, and
36 months old. Follow-up questionnaires were only
completed for 273 children. The population characteris-
tics that were examined for the children included: vac-
cination status, pet exposure, air conditioner exposure,
breast feeding, diet, frequency of viral respiratory infec-
tions, medications, household income, parental educa-
tion, and cohabitation with a smoker. Allergic wheezing
(as a proxy for asthma in children ≤ 5 years old [19]), al-
lergic rhinitis, and allergic eczema were diagnosed by
paediatricians based on clinical manifestations, the pres-
ence of at least one sIgE+, and parent-described patient
symptoms. The cohort belonged to a low economic sta-
tus group (≤20,000 Renminbi income/year) based on
available data from the Statistics Department (http://
www.stats.gov.cn/) on the Per Capita Disposable Income
(PCDI) for the Jilin Province collected from 2012–2015.
Dust collection and analysis
To evaluate the presence of environmental allergens, dust
samples were collected from the living rooms of the preg-
nant women one month before delivery. Dust samples
were subsequently collected from the children’s bedrooms
at 12 ± 1, 24 ± 1, and 36 ± 1 months post delivery. All dust
samples were collected on pre-weighed glass fibre filters.
Collection was performed using vacuum cleaners with
sampling nozzles (ALK, Horsholm, Denmark) according
to a standardized protocol with photo and video instruc-
tions. Collected samples were stored at −20 °C until ex-
traction. Dust-containing filters were weighed and
extracted in a volume of 5–40 ml, as determined by the
net dust weight (<0.5 g, 5 ml; 0.5–1.0 g, 10 ml; 1.0–2.0 g,
20 ml; > 2.0 g, 40 ml). Endotoxin levels were measured
with a kinetic chromogenic Limulus amebocyte lysate
(LAL) test and glucan levels were detected in an inhibition
enzyme immunoassay an inhibition EIA [20].
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IgE detection
Total IgE and sIgE were measured in peripheral blood
serum samples collected from both mothers and children
using the RAST method. Levels of sIgE in serum against six
foods (cow’s milk, hen’s egg, hazelnut, carrot, peanut, and
wheat flour) and 13 inhalant allergens (Dermatophagoides
farinae; Dermatophagoides pteronyssius; cat fur; dog fur;
horse fur; Alternaria species; mugwort, plantain, birch,
alder, hazel, and rye pollen; and grass pollen mix) were
assayed. A positive sIgE was defined as one or more positive
reactions ≥0.35 IU/mL to a panel of 19 common allergens.
Lymphocyte stimulation and cytokine production
Cord blood (20 ml) and peripheral blood (5–10 ml) sam-
ples were collected from healthy neonates within 24 h of
birth. Cord blood mononuclear cells (CBMCs) were iso-
lated from cord blood by density gradient centrifugation
with Ficoll-Paque PLUS (GE Healthcare, Piscataway, NJ,
USA) after dilution in PBS (Gibco, Carlsbad, CA, USA).
Cells were washed in RPMI 1640 (Gibco) and diluted in
10 % human serum (Gibco) to a concentration of 5 × 106
cells/ml. CBMCs were cultured for three days in the
presence of 10 μg/ml PPG, 0.1 μg/ml LPA (Sigma-Aldrich,
St. Louis, MO, USA), or without a stimulation factor.
Concentrations of IL-10, IL-13, IL-17, and interferon-γ
(IFN-γ) in the CBMC supernatants were measured with a
Human Cytokine Multiplex Assay kit (Bio-Rad, Munich,
Germany) with Luminex detection. The lower limits of
detection for the assay (pg/mL) were: 0.9 (IL-10), 2.1
(IL-13), 0.2 (IL-17), and 1.3 (IFN-γ).
Flow cytometry
CBMCs were analysed by flow cytometry (BD Biosci-
ences, San Jose, CA, USA) after three days of cultivation.
For surface staining, 2 μl of anti-human CD4-fluorescein
isothiocyanate (FITC), 1 μl of CD25-RPE-Cy5, 1 μl of
IgG1-FITC (DakoCytomation, Glostrup, Denmark), and
0.5 μl of IgG2a RPE-Cy5 (BD Biosciences) were added.
For CD4/CD25/FOXP3 co-staining, 8 μl of anti-human
CD4-FITC and 4 μl of anti-human CD25-RPE-Cy5 anti-
bodies were added to 1 × 106 cells in 100 ml PBS. Cells
were then permeabilized and FOXP3-PE or the corre-
sponding isotype control antibodies were added. Data
were analysed with CellQuest software (BD Biosciences).
Real-time quantitative RT-PCR
CBMCs were collected after three days of cultivation
and total RNA was isolated immediately with the Tri-
Pure Isolation Reagent (Roche, Mannheim, Germany).
RNA concentration was determined with a Nano-
Drop2000 (Thermo Scientific, Waltham, MA, USA), and
samples were stored at −20 °C. Reverse transcriptase
were performed (Invitrogen, Karlsruhe, Germany) for
cDNA synthesis. Specific primer pairs were designed with
Primer Express software (Vector NTI Advance10). Quanti-
tative real-time PCR was performed with an iCycleriQ-
Table 1 Characteristics of mothers and neonates
Mothers without allergies (n = 234) Mothers with allergies (n = 98) P-value
Maternal age, y (IQR) 26 (23–32) 28 (22–35) 0.26
Body mass index (IQR) 23.15 (19.98–26.89) 22.04 (19.05–28.04) 0.23
Smoking status, n (%)
Non smoking 225 (96.15) 97 (98.98) 0.29
Smoking during pregnancy 0 (0) 0 (0)
Smoking until pregnancy 9 (3.85) 1 (1.02) 0.29
Maternal total IgE, UI/ml (IQR) 26.4 (9.42–57.9) 68.5 (42.5–222.4) 0.005
Maternal allergies [sIgE (+)], n (%) 0 (0) 98 (100)
Asthma 0 (0) 23 (23.47)
Allergic rhinitis 0 (0) 66 (67.35)
Allergic eczema 0 (0) 30 (30.61)
Endotoxins in maternal bedroom, EU/mg (IQR) 14.77 (4.20–55.18) 11.73 (2.64–50.14) 0.10
β (1,3)-glucans in maternal bedroom, μg/mg (IQR) 3.42 (1.04–9.57) 2.33 (0.67–5.88) 0.16
Vaginal delivery, n (%) 210 (89.74) 82 (83.67) 0.14
Male neonate gender, n (%) 120 (51.28) 51 (52.04) 0.90
Gestational age, weeks (SEM) 39.91 (1.20) 39.93 (1.18) 0.94
Birth weight, g (SEM) 3403.3 (407.37) 3610.56 (427.19) 0.45
Birth length, cm (IQR) 51.75 (51.36–52.14) 53 (52.48–53.52) 0.19
Apgar 5 min score > 8, n (%) 234 (100) 98 (100)
Data in boldface are significant with P ≤ 0.05. Data are reported as either the mean (SEM) or median (IQR) depending on the data distribution
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multicolor Real-Time PCR Detection System. SYBR Green
(Applied Biosystems, Darmstadt, Germany) was used to de-
tect double-stranded PCR products. The CT means the
number of PCR cycles which are required for the fluores-
cence signal to exceed the detection threshold value. The
threshold cycle (CT) of each target product is associated
with the amplification plot of 18S. The level of mRNA from
individual gene is described as gene expression. The fold
difference in gene expression was calculated based on the
difference in normalized CT values between the stimulation
and non-stimulation groups. The relative quantitative re-
sults showed changes of gene expressions in stimulated
samples when compared with those in unstimulated ones.
Functional analysis of tregs
CD3− T cells were isolated (CD3− Cell Isolation kit,
MiltenyiBiotec, Köln, Germany) and irradiated as
antigen-presenting cells. CD3− T cell purity reached
98 %. CD4+CD25+ T cells were isolated from CBMCs
by tandem positive selection (MiltenyiBiotec). CD4+CD25
− T cells were collected from the flow through during
CD25 selection. The purity of both the CD4+CD25− and
CD4+CD25+ T cell populations was > 95 %. CD4+CD25− T
cells (effector T cells) were labelled with 5 μmol/L CFSE
(CellTrace™ CFSE Cell Proliferation Kit, Invitrogen), and
were subsequently incubated for three days with irradiated
CD3− cells in co-culture with or without CD4+CD25+ T
cells (Tregs). The co-cultures were stimulated with phyto-
haemagglutinin (0.8 μg/ml). CFSE-stained CD4+CD25− T
cells were isolated by flow cytometry and 3H-thymidine
incorporation was used to measure their proliferation.
Concentrations of cytokines IL-13, IL-17, and IFN-γ were
measured in the cell culture supernatants using a Human
Cytokine Multiplex Assay Kit. The resulting values were
compared between the effector T cells only group and the
effector T cells plus Tregs group. The suppressive capacity
of the Tregs on the effector T cells was further compared
between the maternal allergy and non-allergy groups.
Statistical analysis
Data were analyzed using SigmaStat1.0 software. Differ-
ences in cell counts, gene expression, suppressive func-
tion, and cytokine production for the Tregs present in
the neonate cord blood samples were compared between
maternal allergy and non-allergy groups, and between
children’s allergy and non-allergy groups. Correlations
between newborn Treg function and the development of
childhood allergy were analysed. Metric data were
Table 2 Physical and environmental characteristics of children included in the follow-up study
Children without allergies (n = 202) Children with allergies (n = 71) P-value
Male, n (%) 97 (48.02) 38 (53.52) 0.49
Body weight at 3 years of age, g (SEM) 15.1 (3.47) 16.7 (4.21) 0.14
Height at 3 years of age, cm (IQR) 97.6 (92.1–111.6) 97.4 (91.8–107.2) 0.58
Allergic diseases during 0–3 years of age, n (%)
All allergies [sIgE (+)] 0 (0) 71 (100)
Wheezing 0 (0) 19 (26.76)
Allergic rhinitis 0 (0) 50 (70.42)
Allergic eczema 0 (0) 47 (66.19)
Maternal allergic history, n (%) 62 (30.69) 38 (53.52) 0.001
Average composition in dust from children’s bedrooms
Endotoxin, EU/mg (IQR) 13.65 (3.51–45.78) 11.65 (2.78–39.44) 0.05
β (1,3)-glucans, μg/mg (IQR) 2.67 (0.54–7.45) 2.19 (0.51–5.56) 0.21
Pet exposure, n (%) 5 (2.47) 0 (0) 0.33
Air conditioner exposure, n (%) 22 (10.89) 9 (12.68) 0.54
Breast fed, n (%) 135 (66.83) 50 (70.42) 0.66
Respiratory virus infections, n (%)
< 3 per year 139 (68.81) 47 (66.20) 0.44
3–5 per year 35 (17.33) 14 (19.72) 0.28
> 5 per year 28 (13.86) 10 (14.08) 0.54
Low household income, n (%) 92 (45.54) 26 (36.62) 0.21
Low parental education (middle school and lower), n (%) 35 (17.33) 12 (16.90) 1.0
Co-habitation with a smoker, n (%) 10 (4.95) 3 (4.23) 1.0
Data in boldface are significant with P ≤ 0.05. Data were reported as either the mean (SEM) or median (IQR) depending on the data distribution
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evaluated by either a t-test or the Mann–Whitney rank
test with or without normal distribution. Data are re-
ported as the mean ± standard error of the mean (SEM)
or the median with a 25–75 % interquartile range (IQR),
depending on their distribution. Attributes data were ana-
lyzed with a X2 test or Fisher’s exact test. Multiple logistic
regression was performed for the correlation analyses.
Odds ratio (OR) values were reported when applicable.
Statistical significance was defined as a P-value < 0.05.
Results
Cohort characteristics
Table 1 reports the available data for the 332 mother/
neonate pairs of the present cohort (including 234 pairs
in the maternal non-allergy group and 98 pairs in the
maternal allergy group). Total maternal IgE levels were
significantly higher in the maternal allergy group com-
pared with the maternal non-allergy group (P = 0.005).
Otherwise, there were no distinguishing characteristics
between the mothers of the two groups, except there
were four allergic asthmatic mothers who took low doses
of inhaled glucocorticoids at gestational weeks 20–30.
A follow-up study was conducted for the 273 chil-
dren for whom a completed follow-up questionnaire
was completed at 0–3 years of age (Table 2). There
were 59 children that were lost to follow-up due to a
change in address or telephone number. While ap-
proximately half (53.52 %) of the allergic children had
allergic mothers, only 30.69 % of the non-allergic chil-
dren had allergic mothers. It was observed that the
children with maternal allergy histories were more
prone to allergic diseases (P = 0.001). The average con-
centration of endotoxin dust in the samples collected
from the bedrooms of the allergic children was less
than that in the bedroom samples for the non-allergic
children (P = 0.05). However, there was no difference
in β (1,3)-glucan exposure, diet, frequency of viral re-
spiratory infections, household income, parental edu-
cation, or cohabitation with a smoker between the
children with and without allergies.
Treg abundance and activity
Treg abundance in the CBMCs (characterized as CD4
+CD25+FOXP3+ T cells, Fig. 1) and cytokine production
Fig. 1 Percent of CD4+CD25+FOXP3+ T cells in untreated and stimulated CBMCs. CD4+CD25+FOXP3+ T cell populations were determined by
fluorescent antibody staining and FACS. a Unstimulated CD4+CD25+FOXP3+T cells represented 1.80 % of the CBMC population (=90.8 % * 1.98 %).
b CD4+CD25+FOXP3+T cells represented 1.98 % of the LPA-stimulated CBMC population (=70.14 % * 2.83 %). c CD4+CD25+FOXP3+T cells represented
2.41 % of the PPG-stimulated CBMC population (=49.57 % * 4.87 %). See Methods for details on CBMC culturing, stimulation, and fluorescence staining
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are listed in Table 3. Tregs were less abundant in the
CBMCs collected from the neonates with maternal aller-
gies than in those without allergies, especially following
PPG stimulation (P = 0.01, Table 3). Both PPG/LPA-
stimulated FOXP3, and PPG-stimulated LAG3, gene ex-
pression levels were lower in the neonates with maternal
allergies than in the neonates from mothers without al-
lergies (P < 0.05). Maternal allergic background also af-
fected cytokine responses. IL-10 levels in the PPG-TLR2
innate immune pathway were lower in the offspring
from the mothers with allergies than those from the
mothers without allergies (P = 0.006), in agreement with
the observations in CD4+CD25+FOXP3+T cells and the
FOXP3/LGA3 expression profiles for these groups. Pro-
duction of the Th1 cytokine, IFN-γ, was also reduced
upon LPA and PPG stimulation in the newborns with
allergic mothers compared to the newborns with non-
allergic mothers (P = 0.04 and P = 0.047, respectively),
while increased production of PPG-stimulated IL-13 and
IL-17 was observed as well (P = 0.021 and P = 0.049,
respectively).
In Table 4, Treg abundance, related gene expression,
and cytokine production data are compared for neonate
cord blood samples based on their childhood allergy
Table 4 Tregs and cytokines in CBMCs of offspring with and
without childhood allergies
Children without
allergies (n = 202)
Children with
allergies (n = 71)
P-value
CD4+CD25+ FOXP3+ T cells, % in CBMCs (SEM)
U 1.91 (0.67) 1.17 (0.61) 0.12
LPA 2.15 (0.73) 1.45 (0.54) 0.08
PPG 2.44 (0.63) 1.57 (0.49) 0.01
FOXP3 gene expression, fold difference (IQR)
LPA 3.14 (1.60–5.25) 1.41 (0.70–2.64) 0.01
PPG 4.03 (1.32–6.02) 1.98 (1.25–4.14) 0.02
GITR gene expression, fold difference (IQR)
LPA 2.14 (1.0–5.14) 2.79 (0.96–10.44) 0.12
PPG 2.42 (0.99–6.96) 3.67 (0.95–8.61) 0.44
LAG3 gene expression, fold difference (IQR)
LPA 2.14 (0.61–4.65) 1.19 (0.68–3.36) 0.51
PPG 2.0 (0.54–3.73) 2.22 (0.63–4.74) 0.61
IL-10 production, pg/ml (IQR)
U 0.10 (0.01–0.26) 0.15 (0.01–0.21) 0.35
LPA 177.93 (110.74–229.50) 135.28 (88.14–192.87) 0.09
PPG 1078.74 (730.84–1518.49) 830.74 (623.0–1038.23) 0.016
IL-13 production, pg/ml (IQR)
U 0.16 (0.01–0.37) 0.21 (0.01–0.35) 0.63
LPA 4.5 (1.65–11.83) 5.07 (1.70–13.26) 0.80
PPG 31.70 (12.88–50.53) 30.59 (11.90–61.45) 0.53
IFN-γ production, pg/ml (IQR)
U 1.02 (0.01–1.99) 1.66 (0.45–2.51) 0.09
LPA 5.08 (2.81–16.86) 4.91 (2.82–7.72) 0.55
PPG 13.15 (6.12–30.33) 10.22 (4.96–26.50) 0.53
IL-17 production, pg/ml (IQR)
U 0.01 (0.01–0.47) 0.01 (0.01–0.43) 0.96
LPA 1.71 (0.19–4.39) 0.84 (0.01–2.80) 0.12
PPG 2.94 (1.28–11.41) 2.34 (0.74–6.48) 0.18
U unstimulated, LPA stimulation with 0.1 μg/ml LPA, PPG stimulation with
10 μg/ml PPG
Data in boldface are significant with P ≤ 0.05. Data are reported as the mean
(SEM) or median (IQR) depending on the data distribution







CD4+CD25+ FOXP3+ T cells, % in CBMCs (SEM)
U 1.78 (0.71) 1.57 (0.76) 0.12
LPA 2.05 (0.75) 1.81 (0.76) 0.08
PPG 2.33 (0.69) 1.99 (0.68) 0.01
FOXP3 gene expression, fold difference (IQR)
LPA 3.14 (1.79–5.24) 2.50 (0.83–4.88) 0.021
PPG 3.36 (1.32–4.92) 2.69 (1.22–5.86) 0.024
GITR gene expression, fold difference (IQR)
LPA 2.83 (1.53–6.24) 1.50 (0.95–3.03) 0.16
PPG 3.93 (1.87–8.46) 2.46 (0.95–5.89) 0.15
LAG3 gene expression, fold difference (IQR)
LPA 2.83 (1.39–6.45) 1.53 (0.90–3.03) 0.12
PPG 2.93 (1.88–5.66) 2.00 (0.85–2.95) 0.028
IL-10 production, pg/ml (IQR)
U 0.19 (0.01–0.27) 0.035 (0.01–0.23) 0.81
LPA 173.71 (109.24–198.26) 135.16 (91.37–241.89) 0.43
PPG 1104.47 (806.43–1519.56) 868.44 (603.76–1153.45) 0.006
IL-13 production, pg/ml (IQR)
U 0.16 (0.01–0.33) 0.13 (0.01–0.36) 0.52
LPA 3.81 (1.45–7.80) 5.87 (1.48–13.21) 0.06
PPG 25.44 (12.41–53.98) 33.38 (13.14–61.53) 0.021
IFN-γ production, pg/ml (IQR)
U 1.02 (0.01–1.99) 1.02 (0.45–1.99) 0.49
LPA 5.52 (3.47–17.64) 3.95 (1.64–9.66) 0.04
PPG 14.28 (6.57–33.42) 8.66 (5.02–18.96) 0.047
IL-17 production, pg/ml (IQR)
U 0.09 (0.01–0.47) 0.12 (0.01–0.67) 0.38
LPA 2.39 (0.24–4.39) 2.26 (0.81–4.10) 0.86
PPG 2.7 (1.65–10.99) 4.03 (2.74–19.25) 0.049
U unstimulated, LPA stimulation with 0.1 μg/ml LPA, PPG stimulation with
10 μg/ml PPG
Data in boldface are significant with P ≤ 0.05. Data are reported as the mean
(SEM) or median (IQR) depending on the data distribution
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status, independent of maternal allergy status. Children
with allergies had a lower number of PPG-stimulated CD4
+CD25+FOXP3+T cells (P = 0.01), reduced FOXP3 expres-
sion in response to PPG and LPA (P = 0.02 and P = 0.01,
respectively), and lower IL-10 production (P = 0.016),
compared to the children without allergies.
The suppressive capacity of tregs
Tregs from the children with allergic mothers suppressed
the division and proliferation of effector T cells less effi-
ciently than the Tregs from the children with non-allergic
mothers (P = 0.03 and P = 0.01, respectively; Fig. 2). The
Tregs of the former group also exhibited a significant de-
cline in the production of IL-13 compared to the latter
group (P = 0.026, Fig. 2). In contrast, production of IL-17
and IFN-γ were unaffected (P > 0.05, Fig. 2).
Risk factors for allergic diseases
Maternal allergy was a significant risk factor for de-
veloping allergic diseases (OR = 2.46, 95 % CI = 1.05–
5.79; Table 5). After adjusting for maternal allergy,
environmental exposure, diet, frequency of viral respiratory
infections, household income, parental education, and co-
habitation with a smoker as factors, the percent of CD4
+CD25+FOXP3+T cells in the PPG-stimulated cord blood
samples was found to negatively correlate with allergy sta-
tus, allergic rhinitis, and allergic eczema in children, yet
not with wheezing (Table 6). Conversely, a decrease in the
percent of CD4+CD25+FOXP3+ T cells in the unstimulated
cord blood samples was identified as a risk factor for
wheezing (adjusted OR = 0.017, 95 % CI = 0.001–0.46;
Table 6). Decreased PPG-stimulated IL-10 production, as
well as decreased LPA-stimulated and PPG-stimulated
FOXP3 expression, in cord blood were further identified as
risk factors for a positive allergic status in children and al-
lergic rhinitis (Tables 7 and 8, respectively).
Discussion
In this birth cohort study, Tregs in the cord blood sam-
ples obtained from neonates with allergic mothers were
fewer in number. The Tregs also exhibited compro-
mised suppressive function, lower levels of expression
for associated genes, and decreased IL-10 production.
Moreover, the PPG-TLR2 innate immune response
Fig. 2 In vitro suppression of effector T cells by neonate Tregs. a Effector T cell division in the presence and absence of Tregs as determined by
CFSE staining. b Effector T cell proliferation in the presence and absence of Tregs as determined by 3H-thymidine incorporation. c-e Effector T cell
secretion of IFN-γ, IL-13, and IL-17 in the presence and absence of Tregs as measured by LUMINEX. Te: effector T cells; Tr: regulatory T cells (n = 8)
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pathway was particularly affected. As a result, an
increased susceptibility to allergies in early childhood
(0–3 years old) was observed. Maternal allergic disease
history and neonatal impairment of Tregs were both
identified as risk factors for susceptibility to allergies in
the children examined, independent of social and envir-
onmental factors for the children and their families.
These results are consistent with those of previous
studies of allergies in European populations [4, 5].
Many studies have reinforced the importance of in
utero exposure for fetal immune development and the
programming of susceptibility to asthma and allergic dis-
eases [21]. In the present study, these factors were ad-
equately considered to avoid potential interference. In
addition, based on the results of a study by Schaub et al.
where a higher percentage of allergic neonates with al-
lergic mothers were more likely to have allergic fathers
[5], paternal allergies were established as an exclusion
criterion for the present study in order to focus on the
effect of maternal allergic disease history on offspring.
The study by Schaub et al. also reported increased birth
weights and lengths for the newborns with allergic
mothers [5]. However, no differences in birth weight or
length between the groups of the present study were ob-
served. This may be due to the similarity in the diets
and medication use of the mothers included in the
present cohort. Over the course of child development,
many social and environmental factors should be consid-
ered when assessing influences on allergy development.
Therefore, factors which have been shown to influence
allergic disease development in children were considered
in the present study, including: environmental exposure,
diet, frequency of viral respiratory infections, household
income, parental education, and co-habitation with a
smoker [22]. It was observed that the endotoxin content
in the living environments of the children with allergies
was lower than in the living environments of the chil-
dren without allergies. These results are consistent with
those from Karvonen et al. where endotoxin exposure in
early life was found to be closely related to the develop-
ment of allergic diseases in children [23]. Consequently,
microbial content was adjusted for in the analyses of risk
factors for children’s allergic status.
As shown in Fig. 1a, b and c, FOXP3+ T cells repre-
sented > 90 % of the unstimulated CD4+CD25+ T cells.
Therefore, CD4+CD25+ T cells were isolated from the
unstimulated CBMCs to serve as a Treg population that
would have its suppressive function examined in vitro.
There were fewer CD4+CD25+FOXP3+ T cells present in
both the neonates with allergic mothers and the neo-
nates who developed allergies in early childhood. While
the expression levels of GITR, LAG3, and FOXP3 were
previously shown to positively correlate with each other
[5], the specificity and sensitivity of their expression
slightly differed in the TLR-mediated innate immune re-
sponses that were induced. It has been shown that Tregs
secreting IL-10 play an important role in allergic dis-
eases, independent of CD25+ Tregs [12]. Therefore, IL-
10 production was assayed as a readout of function for
this Treg subgroup. However, IL-10 is also secreted from
Th2 cells. In the present data, PPG-stimulation reduced
IL-10 secretion in the newborns with allergic mothers,
while secretion of the Th2-specific cytokine, IL-13, in-
creased (Table 3). These results suggest that IL-10 pro-
duction is characteristic of this Treg subgroup in the
TLR-mediated innate immune response. Overall, the risk
factors for allergies in children of the present cohort in-
cluded a reduced percentage of CD4+CD25+FOXP3+ T
Table 6 Association of allergy in children with % CD4+CD25+ FOXP3+ T in neonate CBMCs
Adjusted OR (95 % CI) P-value
Unstimulated LPA-stimulated PPG-stimulated
All allergies 0.51 (0.18–1.51) 0.228 0.65 (0.23–1.85) 0.416 0.12 (0.04–0.43) 0.01
Allergic wheezing 0.017 (0.001–0.46) 0.016 2.15 (0.35–13.39) 0.41 0.36 (0.046–2.77) 0.32
Allergic rhinitis 0.49 (0.148–1.60) 0.23 0.39 (0.12–1.28) 0.12 0.26 (0.074–0.91) 0.035
Allergic eczema 1.08 (0.36–3.29) 0.88 0.57 (0.18–1.80) 0.34 0.16 (0.044–0.56) 0.04
Data in boldface are significant with P ≤ 0.05. Data were adjusted for maternal allergy, environmental and social factors
Table 5 Association of allergy in children with maternal allergic history and endotoxin or β (1, 3)-glucan exposure
OR (95 % CI) P-value
Maternal allergic history Endotoxin (EU/mg) β (1,3)-Glucans (μg/mg)
All allergies 2.46 (1.05–5.79) 0.03 0.90 (0.75–1.02) 0.15 1.05 (0.95–1.16) 0.27
Allergic wheezing 3.02 (0.68–13.35) 0.14 0.88 (0.75–1.03) 0.11 1.06 (0.92–1.20) 0.42
Allergic rhinitis 2.13 (0.815–5.56) 0.12 0.93 (0.85–1.01) 0.17 1.01 (0.95–1.07) 0.68
Allergic eczema 3.21 (1.18–8.69) 0.02 0.94 (0.84–1.06) 0.35 1.03 (0.93–1.15) 0.54
Data in boldface are significant with P ≤ 0.05
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cells, reduced FOXP3 expression, and PPG-stimulated
IL-10 secretion (Tables 6, 7 and 8). However, the other
cytokines assayed, IL-13, INF-γ, and IL-17, were not
identified as risk factors (data not shown). To date,
the traditional Th1/Th2 imbalance theory has not
been sufficient to explain the complex pathogenesis
for allergic diseases. In addition, Tregs, Th17 cells,
Th9 cells, and other subgroups of T cells have all
been implicated in allergic disease pathogenesis. Based
on the importance of Tregs maintaining their sup-
pressive function, we hypothesize that impairment of
Tregs in neonates with allergic mothers leads to dys-
regulation of the differentiation of Th0 cells into Th1,
Th2, and Th17 cells, and this is the driving force for
allergy development in children.
When the children of this study were divided into
those with or without allergies, regardless of maternal al-
lergy status, down-regulation of Tregs according to the
TLR2/4 pathway at the newborn stage partly predicted
the children’s allergic status. However, it was not clear
whether the down-regulation of Tregs derived exclu-
sively from maternal allergy history. By using multiple
logistic regression, exclusion of maternal allergic disease
history and environmental factors led to the identifica-
tion of a reduced number of CD4+CD25+FOXP3+ T
cells, reduced FOXP3 gene expression, and reduced IL-
10 secretion in neonates as independent risk factors for
the allergic status of children (Tables 6, 7, and 8).
It was previously demonstrated that impairment of
Tregs in neonates with allergic mothers was more pro-
found in the TLR2/4-mediated innate immune response
pathways, due in part to genetic variations in the TLRs
present in cord blood [24]. Genetic-immunological
interactions of the TLR pathway influence Tregs early in
life and are modulated by maternal allergic disease his-
tory. Moreover, it is likely these interactions are relevant
for immune maturation in the development of allergic
diseases in childhood. In addition to a genetic compo-
nent, the time, frequency, and intensity of activation of
TLR-mediated immune pathways are important for the
maturation and differentiation of Tregs and other Th
cells. For instance, increased microorganism exposure in
early life in children and in mouse models has been
shown to regulate the immune system by enhancing the
Th1 pathway and weakening the Th2 pathway through
TLR2/4 immune responses [25–27].
The results of the present study have revealed that ma-
ternal allergy status has a significant impact on Treg dif-
ferentiation in the TLR2/4 immune pathway, yet not in
the unstimulated pathway. The present results also con-
firm that the occurrence of allergic disease is the result
of interactions between genetic and environmental fac-
tors. In particular, the neonatal period appears to be a
key immune maturation period, and environmental
endotoxin levels during this period can influence the ex-
tent of differentiation that takes place to generate differ-
ent T cell subgroups in children via the TLR2/4 pathway.
The number of Tregs present in fetal umbilical cord
blood was observed to increase following PPG and LPA
stimulation, thereby facilitating the differentiation of
naive T cells into new Tregs. Maternal allergy history
can influence modulation of differentiation and inhibit
the differentiation rate of Tregs through the interactions
of other T cell subgroups.
Thorburn et al. [28] showed that high fibre or acetate
diets during pregnancy, which influence gut microbiota,
can lead to marked suppression of allergic airway dis-
eases in offspring by enhancing Treg numbers and func-
tion. These results are consistent with the observation
that the intake of probiotics during pregnancy and early
life have the potential to prevent childhood eczema [29]
and IgE-associated allergies to some extent [30]. How-
ever, avoiding activation of the TLR-mediated immune
pathway appears safer than a desensitization approach
for preventing allergic disease development in the off-
spring of allergic pregnant women since the latter can
up-regulate CD4+CD25+ T cells and IL-10 production in
Table 8 Association of allergy in children with FOXP3 expression
Adjusted OR (95 % CI) P-value
LPA-stimulated PPG-stimulated
All allergies 0.78 (0.63–0.97) 0.04 0.80 (0.65–0.97) 0.05
Allergic wheezing 0.78 (0.52–1.16) 0.22 0.76 (0.52–1.13) 0.18
Allergic rhinitis 0.77 (0.59–0.99) 0.05 0.85 (0.69–1.04) 0.12
Allergic eczema 0.83 (0.66–1.04) 0.11 0.81 (0.64–1.03) 0.08
Data in boldface are significant with P ≤ 0.05. Data were adjusted for maternal
allergy, environmental, and social factors
Table 7 Association of allergy in children with Treg-specific cytokine IL-10 levels
Adjusted OR (95 % CI) P-value
Unstimulated LPA-stimulated PPG-stimulated
All allergies 0.17 (0.01–2.34) 0.19 0.65 (0.25–1.67) 0.37 0.33 (0.13–0.86) 0.03
Allergic wheezing 1.16 (0.07–18.98) 0.91 0.33 (0.07–1.51) 0.15 0.69 (0.15–3.26) 0.64
Allergic rhinitis 0.21 (0.07–5.94) 0.35 1.27 (0.41–3.98) 0.68 0.29 (0.09–0.89) 0.04
Allergic eczema 0.14 (0.04–4.97) 0.28 0.81 (0.27–2.43) 0.70 0.50 (0.17–1.46) 0.21
Data in boldface are significant with P ≤ 0.05. Data were adjusted for maternal allergy, environmental, and social factors
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offspring [31, 32]. In the risk factor analysis performed
in the present study, a decrease in PPG-stimulated Tregs
was identified as a risk factor for children’s allergic sta-
tus, allergic rhinitis, and allergic eczema. Meanwhile, a
decrease in unstimulated Tregs was only a risk factor for
allergic wheezing. Thus, micro-stimulation of the TLR2
and TLR4 pathways with adjustment of diet and envir-
onmental exposure may be an effective early interven-
tion for preventing allergic disease in neonates that have
lower numbers of Tregs or that have a maternal allergic
disease history by establishing a more beneficial Th1/
Treg balance.
Conclusions
In summary, maternal allergic disease history and defi-
ciency in Tregs in newborns are risk factors for the de-
velopment of allergic diseases in children. The
impairment of Tregs number and function in neonates
could lead to susceptibility to allergic status and diseases
through the imbalance of Th1/2 and Th17 cells. Because
deficiency in Tregs is more obvious in the TLR2-
mediated innate immune response pathway, we could
seek possible micro-stimulation to up-regulate Tregs in
the TLR2 pathway and provide early prevention for aller-
gic diseases in children with maternal allergic histories.
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